How Lanton Strategies represents healthcare providers, health systems, biotechnology companies and pharmaceutical manufacturers before state legislatures and regulatory agencies.
By Ron Lanton
A bill introduced in Massachusetts, New York or another Northeastern state can change how a hospital gets paid, how a pharmacy operates or how a biotechnology company brings a new treatment to market. For healthcare executives, those decisions can have financial consequences long before a new law takes effect.
State legislators regularly consider proposals involving pharmacy benefit managers (PBMs), prescription drug pricing, the 340B Drug Pricing Program, healthcare reimbursement, professional licensing and patient access. These issues affect healthcare organizations differently, depending on their operations and where they do business.
For companies operating in the Northeast, understanding what lawmakers are considering is only part of the job. They also need someone who can explain how a proposal could affect their business and represent their interests before decisions are made.
What Lanton Strategies Does
Lanton Strategies works with healthcare providers, health systems, pharmacies, biotechnology companies, pharmaceutical manufacturers, medical technology businesses and industry associations on state legislative and regulatory matters.
Our government affairs work includes monitoring legislation, meeting with legislators and committee staff, preparing testimony, developing policy positions and working with state agencies.
We also represent clients throughout the regulatory process. Once legislation becomes law, state agencies may develop regulations, issue guidance and establish requirements that determine how the law operates. We help clients participate in rulemaking, submit comments, communicate with regulators and address implementation concerns.
This allows us to work with clients from the introduction of legislation through the regulations and administrative decisions that follow.
For a health system, that might involve hospital reimbursement or 340B legislation. For a pharmaceutical manufacturer, it could involve drug pricing, distribution or patient access. Biotechnology and medical technology companies may need representation on coverage requirements, research policy or regulations affecting their products.
Why Companies Hire Us
Healthcare executives have businesses to run. They cannot spend every day following legislative hearings, reviewing proposed amendments or meeting with government officials.
Lanton Strategies combines healthcare regulatory knowledge with experience representing organizations before policymakers. We understand how legislation and regulations can affect reimbursement, business operations and patient care.
Timing matters. Waiting until a bill reaches a final vote, or until an agency issues its final regulations, can leave little opportunity to explain concerns or request changes.
Our job is to represent our clients throughout the legislative and regulatory process, from the first policy proposal to the rules that determine how it is implemented.
If your organization needs government affairs or regulatory representation in Massachusetts, New York or elsewhere in the Northeast, contact Lanton Strategies to discuss your legislative and regulatory priorities.
Ron Lanton is President of Lanton Strategies International and Senior Partner and Global Strategist at Lanton, Lanton & Sosa Law PLLC.
Government affairs services are subject to applicable state lobbying registration requirements.